Cumberland Pharmaceuticals (CPIX) Short-Term Debt issuances (2016 - 2024)
Historic Short-Term Debt issuances for Cumberland Pharmaceuticals (CPIX) over the last 12 years, with Q4 2024 value amounting to $5.5 million.
- Cumberland Pharmaceuticals' Short-Term Debt issuances fell 2857.14% to $5.5 million in Q4 2024 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 8648.28%. This contributed to the annual value of $38.5 million for FY2024, which is 2228.41% up from last year.
- As of Q4 2024, Cumberland Pharmaceuticals' Short-Term Debt issuances stood at $5.5 million, which was down 2857.14% from $11.0 million recorded in Q3 2024.
- Cumberland Pharmaceuticals' Short-Term Debt issuances' 5-year high stood at $20.0 million during Q1 2022, with a 5-year trough of $5.5 million in Q4 2024.
- For the 5-year period, Cumberland Pharmaceuticals' Short-Term Debt issuances averaged around $12.0 million, with its median value being $11.0 million (2024).
- Per our database at Business Quant, Cumberland Pharmaceuticals' Short-Term Debt issuances soared by 8823.53% in 2021 and then crashed by 6000.0% in 2023.
- Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Short-Term Debt issuances stood at $15.0 million in 2020, then decreased by 6.67% to $14.0 million in 2021, then tumbled by 55.71% to $6.2 million in 2022, then grew by 24.19% to $7.7 million in 2023, then fell by 28.57% to $5.5 million in 2024.
- Its last three reported values are $5.5 million in Q4 2024, $11.0 million for Q3 2024, and $11.0 million during Q2 2024.